Trial Profile
An Open, Randomized, Controlled, Parallel Group, Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate Together With a Randomized Placebo Controlled Double Blind Fermagate Comparison in Hemodialysis Patients With Hyperphosphatemia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fermagate (Primary) ; Lanthanum carbonate
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors INEOS Silicas
- 27 May 2014 New trial record